←Back to Expert Scholars
Translational Medicine / 转化医学Metastatic Breast Cancer, Clinical Development
Stefan Glueck
MD, PhD
🏢Celgene / Bristol Myers Squibb🌐USA
Clinical Director and Oncologist
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Stefan Glueck has led clinical development programs in metastatic breast cancer including work on cytotoxic and targeted combinations. His academic career includes leadership of breast oncology at the University of Miami. He continues to guide oncology drug development.
Share:
🧪Research Fields 研究领域
metastatic breast cancer
clinical development
chemotherapy
drug safety
oncology trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Stefan Glueck 的研究动态
Follow Stefan Glueck's research updates
留下邮箱，当我们发布与 Stefan Glueck（Celgene / Bristol Myers Squibb）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment